Company Stemtech Corporation

STEK

US85859W1027

Pharmaceuticals

Market Closed - OTC Markets 23:54:06 26/10/2026 +04			5-day change	1st Jan Change
0.000100 ^USD	0.00%		0.00%	-87.50%

08-15	Stemtech Corporation Reports Earnings Results for the Second Quarter and Six Months Ended June 30, 2026	CI
06-23	Stemtech Corporation Reports Earnings Results for the First Quarter Ended March 31, 2026	CI

Business description: Stemtech Corporation

Stemtech Corporation is a global network marketing company developing science-based wellness products focused on supporting healthy stem cell physiology. As the Stem Cell Nutrition Company, it specializes in stem cell science, offering products that enhance the function of the bodyâ€™s natural stem cells. These products are designed to aid in the release, circulation, and migration of adult stem cells to tissues for optimal renewal and health. The Company markets its products internationally through subsidiaries and a network of independent distributors. Its product brands include RCM System, stemrelease3, Stemflo, MigraStem, OraStem, Cellect One Rapid Renew Stem Cell Peptide Night Cream, Cellect One Shield HOCL (Hypochlorous Acid Skin Care), and StemPets (Nutritional supplement for dogs and cats). Its OraStem Toothpaste is a multi-functional, stem cell-attracting toothpaste that also whitens teeth, freshens breath, and promotes gum health.

Sales by Activity: Stemtech Corporation

Fiscal Period: December	2021 (USD)	2022 (USD)	2023 (USD)	2024 (USD)	2025 (USD)
Vitamins & Nutrition Products	4.32M	4.56M	4.92M	5.05M	2.88M

See all business segments

Geographical breakdown of sales: Stemtech Corporation

Fiscal Period: December	2021 (USD)	2022 (USD)	2023 (USD)	2024 (USD)	2025 (USD)
Latin America	1.67M	2.5M	3.07M	2.67M	1.53M
Americas	1.87M	1.55M	1.68M	2.17M	1.23M
Asia	787K	511K	180K	215K	117K

See all geographic segments

Executive Committee: Stemtech Corporation

Manager	Title	Age	Since
Charles Arnold CEO	Chief Executive Officer	75	19/08/2021
Shrilakshmi Vadlapatla DFI	Director of Finance/CFO	41	15/04/2025
John Meyer PSD	President	72	19/08/2021
Lizette Leos Lopez CTO	Chief Tech/Sci/R&D Officer	-	06/01/2026
I. Obuz ADM	Chief Administrative Officer	56	21/04/2023

See STEMTECH CORPORATION governance

Composition of the Board of Directors: Stemtech Corporation

Director	Title	Age	Since
Charles Arnold CHM	Chairman	75	19/08/2021
John Meyer BRD	Director/Board Member	72	19/08/2021
Benjamin Kaplan BRD	Director/Board Member	54	17/09/2021
John Thatch BRD	Director/Board Member	63	17/09/2021
Darryl Green BRD	Director/Board Member	61	17/09/2021

Composition of the Board of Directors

Shareholders: Stemtech Corporation

Name	Stocks	%	Valuation
Charles Arnold 2.072 %	62,097,159	2.072 %	6 210 $
Darryl Green 1.629 %	48,821,073	1.629 %	4 882 $
John Meyer 1.542 %	46,201,445	1.542 %	4 620 $
Benjamin Kaplan 1.54 %	46,160,233	1.54 %	4 616 $
John Thatch 1.512 %	45,311,316	1.512 %	4 531 $

List of STEMTECH CORPORATION shareholders

Company details: Stemtech Corporation

Stemtech Corp.

4851 Tamiami Trail North

34103, Naples

http://www.stemtech.com

Biopharmaceuticals

Add to a list 0 selected To use this feature you must be a member Log in Sign up	Change	5-day change	1-year change	3-year change	Capi.($)
STEMTECH CORPORATION	0.00%	0.00%	-98.51%	-99.71%	300K
ELI LILLY AND COMPANY	+0.45%	+3.13%	+54.96%	+125.16%	1,140B
JOHNSON & JOHNSON	+0.94%	+4.93%	+39.86%	+78.72%	641B
ABBVIE INC.	+0.39%	+1.44%	+25.77%	+97.48%	507B
ROCHE HOLDING AG	+1.43%	+4.31%	+46.20%	+67.12%	383B
MERCK & CO., INC.	-3.21%	-2.10%	+60.72%	+33.22%	347B
NOVARTIS AG	-0.41%	+2.64%	+22.48%	+49.82%	293B
ASTRAZENECA PLC	+0.23%	+3.66%	+2.57%	+23.69%	266B
AMGEN INC.	+1.22%	+4.63%	+52.40%	+64.85%	240B
GILEAD SCIENCES, INC.	+1.70%	+3.67%	+31.21%	+102.15%	197B
Average	+0.24%	+2.63%	+23.77%	+54.25%	401.38B
Weighted average by Cap.	+0.44%	+2.98%	+41.37%	+83.80%